Drug–drug interactions in nursing home residents: analysis from the COME-ON trial.

Background as a result of the high prevalence of polypharmacy in nursing homes (NHs), nursing home residents (NHRs) are exposed to numerous drug–drug interactions (DDIs) that can lead to adverse drug effects, and increased morbidity and mortality. Objectives to evaluate (i) the prevalence of DDIs am...

Descripción completa

Detalles Bibliográficos
Publicado en:Age & Ageing Vol. 52; no. 1; pp. 1 - 6
Autores principales: Lion, Simon, Evrard, Perrine, Foulon, Veerle, Spinewine, Anne
Formato: Artículo
Publicado: Oxford University Press / USA Jan2023
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=161698631&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 161698631
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00020729
        AGA
      jtl: Age & Ageing
      issn: 00020729
      maglogo: N
    pubinfo:
      dt: Jan2023
      vid: 52
      iid: 1
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        161698631
        10.1093/ageing/afac278
      ppf: 1
      ppct: 5
      formats:
      tig:
        atl: Drug–drug interactions in nursing home residents: analysis from the COME-ON trial.
      aug:
        au:
          Lion, Simon
          Evrard, Perrine
          Foulon, Veerle
          Spinewine, Anne
        affil:
          Clinical Pharmacy Research Group, Louvain Drug Research Institute, UCLouvain , Brussels, Belgium
          Department of Pharmaceutical and Pharmacological Sciences, KU Leuven , Leuven, Belgium
          Pharmacy Department, UCLouvain, CHU UCL Namur , Yvoir, Belgium
      su:
        Belgium
        Diseases
        Randomized controlled trials
        Drug side effects
        Prevention of drug side effects
        Mortality risk factors
        Cluster sampling
        Statistics
        Multiple regression analysis
        Polypharmacy
        Inappropriate prescribing (Medicine)
        Drug interactions
        Descriptive statistics
        Research funding
        Statistical sampling
        Data analysis
      sug:
        subj:
          Diseases
          Randomized controlled trials
          Drug side effects
          Belgium
          Marketing Research and Public Opinion Polling
          Prevention of drug side effects
          Mortality risk factors
          Cluster sampling
          Statistics
          Multiple regression analysis
          Polypharmacy
          Inappropriate prescribing (Medicine)
          Drug interactions
          Descriptive statistics
          Research funding
          Statistical sampling
          Data analysis
      keyword:
        drug–drug interactions
        nursing homes
        older adults
        older people
        polypharmacy
        drug–drug interactions
        nursing homes
        older adults
        older people
        polypharmacy
      ab: Background as a result of the high prevalence of polypharmacy in nursing homes (NHs), nursing home residents (NHRs) are exposed to numerous drug–drug interactions (DDIs) that can lead to adverse drug effects, and increased morbidity and mortality. Objectives to evaluate (i) the prevalence of DDIs among NHRs and its evolution over time, and (ii) factors associated with a favourable evolution. Design posthoc analysis of the COME-ON study, a cluster-randomised controlled trial aiming at reducing potentially inappropriate prescriptions in NHs, through the implementation of a complex intervention. Setting and subjects 901 NHRs from 54 Belgian NHs. Methods DDIs were identified using a validated list of 66 potentially clinically relevant DDIs in older adults. We defined a favourable evolution at 15 months as the resolution of at least one DDI present at baseline, without the introduction of any new DDI. Factors associated with a favourable evolution were analysed using multivariable logistic regression. Results at baseline, 475 NHRs (52.7%) were exposed to at least 1 DDI and 225 NHRs (25.0%) to more than one DDI. Most common DDI was 'Concomitant use of at least three central nervous system active drugs'. At 15 months, we observed a 6.3% absolute decrease in DDI prevalence in intervention group, and a 1.0% absolute increase in control group. The intervention, older age and private NH ownership were significantly associated with a favourable DDI evolution. Conclusion a high prevalence of DDI in Belgian NHs was observed, but the COME-ON intervention was associated with a favourable evolution over time.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N